Literature DB >> 22968460

Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.

Matthew F Whelihan1, Vicentios Zachary, Thomas Orfeo, Kenneth G Mann.   

Abstract

Prothrombin activation can proceed through the intermediates meizothrombin or prethrombin-2. To assess the contributions that these 2 intermediates make to prothrombin activation in tissue factor (Tf)-activated blood, immunoassays were developed that measure the meizothrombin antithrombin (mTAT) and α-thrombin antithrombin (αTAT) complexes. We determined that Tf-activated blood produced both αTAT and mTAT. The presence of mTAT suggested that nonplatelet surfaces were contributing to approximately 35% of prothrombin activation. Corn trypsin inhibitor-treated blood was fractionated to yield red blood cells (RBCs), platelet-rich plasma (PRP), platelet-poor plasma (PPP), and buffy coat. Compared with blood, PRP reconstituted with PPP to a physiologic platelet concentration showed a 2-fold prolongation in the initiation phase and a marked decrease in the rate and extent of αTAT formation. Only the addition of RBCs to PRP was capable of normalizing αTAT generation. FACS on glycophorin A-positive cells showed that approximately 0.6% of the RBC population expresses phosphatidylserine and binds prothrombinase (FITC Xa·factor Va). These data indicate that RBCs participate in thrombin generation in Tf-activated blood, producing a membrane that supports prothrombin activation through the meizothrombin pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968460      PMCID: PMC3488894          DOI: 10.1182/blood-2012-05-427856

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Plasma viscosity as a cardiovascular risk factor.

Authors:  W Koenig; V Hombach; E Ernst; M Sund; W Mraz; U Keil
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

2.  Reticulocyte counting using flow cytometry.

Authors:  P R Nobes; A B Carter
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

3.  Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles.

Authors:  S Krishnaswamy; K C Jones; K G Mann
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

4.  The relation of blood platelets to hemorrhagic disease. By W.W. Duke.

Authors:  W W Duke
Journal:  JAMA       Date:  1983-09-02       Impact factor: 56.272

5.  Functional prothrombinase complex assembly on isolated monocytes and lymphocytes.

Authors:  P B Tracy; M S Rohrbach; K G Mann
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

6.  Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells.

Authors:  J Connor; C C Pak; A J Schroit
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

7.  Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism.

Authors:  S Krishnaswamy; W R Church; M E Nesheim; K G Mann
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

8.  Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages.

Authors:  L McEvoy; P Williamson; R A Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction.

Authors:  S Krishnaswamy; K G Mann; M E Nesheim
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

10.  Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

Authors:  J W Yarnell; I A Baker; P M Sweetnam; D Bainton; J R O'Brien; P J Whitehead; P C Elwood
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  57 in total

1.  Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk.

Authors:  Suely Meireles Rezende; Willem M Lijfering; Frits R Rosendaal; Suzanne C Cannegieter
Journal:  Haematologica       Date:  2013-07-26       Impact factor: 9.941

2.  Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.

Authors:  Christoph Klatt; Irena Krüger; Saskia Zey; Kim-Jürgen Krott; Martina Spelleken; Nina Sarah Gowert; Alexander Oberhuber; Lena Pfaff; Wiebke Lückstädt; Kerstin Jurk; Martin Schaller; Hadi Al-Hasani; Jürgen Schrader; Steffen Massberg; Konstantin Stark; Hubert Schelzig; Malte Kelm; Margitta Elvers
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

3.  Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.

Authors:  F Semeraro; C T Ammollo; N L Esmon; C T Esmon
Journal:  J Thromb Haemost       Date:  2014-08-26       Impact factor: 5.824

Review 4.  Fibrinogen and red blood cells in venous thrombosis.

Authors:  Maria M Aleman; Bethany L Walton; James R Byrnes; Alisa S Wolberg
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

5.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

6.  The red blood cell death receptor and thrombosis.

Authors:  Nigel Mackman
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

7.  The contribution of red blood cells to thrombin generation in sickle cell disease: meizothrombin generation on sickled red blood cells.

Authors:  M F Whelihan; M J Mooberry; V Zachary; R L Bradford; K I Ataga; K G Mann; N S Key
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

Review 8.  Drug delivery by erythrocytes: "Primum non nocere".

Authors:  Carlos H Villa; Jerard Seghatchian; Vladimir Muzykantov
Journal:  Transfus Apher Sci       Date:  2016-10-31       Impact factor: 1.764

Review 9.  New findings on venous thrombogenesis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Hamostaseologie       Date:  2016-11-23       Impact factor: 1.778

10.  Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Authors:  H M H Spronk; T Padro; J E Siland; J H Prochaska; J Winters; A C van der Wal; J J Posthuma; G Lowe; E d'Alessandro; P Wenzel; D M Coenen; P H Reitsma; W Ruf; R H van Gorp; R R Koenen; T Vajen; N A Alshaikh; A S Wolberg; F L Macrae; N Asquith; J Heemskerk; A Heinzmann; M Moorlag; N Mackman; P van der Meijden; J C M Meijers; M Heestermans; T Renné; S Dólleman; W Chayouâ; R A S Ariëns; C C Baaten; M Nagy; A Kuliopulos; J J Posma; P Harrison; M J Vries; H J G M Crijns; E A M P Dudink; H R Buller; Y M C Henskens; A Själander; S Zwaveling; O Erküner; J W Eikelboom; A Gulpen; F E C M Peeters; J Douxfils; R H Olie; T Baglin; A Leader; U Schotten; B Scaf; H M M van Beusekom; L O Mosnier; L van der Vorm; P Declerck; M Visser; D W J Dippel; V J Strijbis; K Pertiwi; A J Ten Cate-Hoek; H Ten Cate
Journal:  Thromb Haemost       Date:  2018-01-29       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.